BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20683403)

  • 1. Correlation between macroscopic and microscopic diseases on splenectomies performed in the surgical management of ovarian cancer.
    Uzan C; Bontoux LM; Gouy S; Duvillard P; Pautier P; Lhommé C; Morice P
    Int J Gynecol Cancer; 2010 Aug; 20(6):965-70. PubMed ID: 20683403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer.
    Xiang L; Tu Y; He T; Shen X; Li Z; Wu X; Yang H
    J Gynecol Oncol; 2016 Nov; 27(6):e62. PubMed ID: 27550408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenectomy in recurrent epithelial ovarian cancer.
    Gemignani ML; Chi DS; Gurin CC; Curtin JP; Barakat RR
    Gynecol Oncol; 1999 Mar; 72(3):407-10. PubMed ID: 10053114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience.
    Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
    Anticancer Res; 2015 Oct; 35(10):5649-54. PubMed ID: 26408738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenectomy during secondary cytoreductive surgery for epithelial ovarian cancer.
    Hanprasertpong J; Ohishi R; Iwasa N; Nagao S; Okamoto K; Fujiwara K
    Asian Pac J Cancer Prev; 2010; 11(2):413-6. PubMed ID: 20843126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenectomy as Part of Cytoreductive Surgery in Recurrent Epithelial Ovarian Cancer.
    Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
    Anticancer Res; 2015 Sep; 35(9):5097-101. PubMed ID: 26254413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic Splenectomy for Secondary Cytoreduction in Ovarian Cancer Patients With Localized Spleen Recurrence: Feasibility and Technique.
    Gallotta V; Nero C; Lodoli C; Chiantera V; Pacelli F; Fagotti A; Costantini B; Scambia G
    J Minim Invasive Gynecol; 2016; 23(3):425-8. PubMed ID: 26776676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenectomy during secondary cytoreduction for ovarian cancer disease recurrence: surgical and survival data.
    Manci N; Bellati F; Muzii L; Calcagno M; Alon SA; Pernice M; Angioli R; Panici PB
    Ann Surg Oncol; 2006 Dec; 13(12):1717-23. PubMed ID: 16957965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenectomy and surgical cytoreduction in epithelial ovarian cancer: a review.
    Hanprasertpong J; Fujiwara K
    Eur J Cancer Care (Engl); 2011 May; 20(3):287-93. PubMed ID: 20825460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
    Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based cohort follow-up study of all patients operated for borderline ovarian tumor in western Sweden during an 11-year period.
    Akeson M; Zetterqvist BM; Dahllöf K; Jakobsen AM; Brännström M; Horvath G
    Int J Gynecol Cancer; 2008; 18(3):453-9. PubMed ID: 18476948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenectomy and surgical cytoreduction for ovarian cancer.
    Chen LM; Leuchter RS; Lagasse LD; Karlan BY
    Gynecol Oncol; 2000 Jun; 77(3):362-8. PubMed ID: 10831343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Splenectomy in epithelial ovarian cancer: analysis of 32 cases].
    Zheng AW; Zheng F; Chen YQ; Zhu HN; Qian JH
    Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):197-200. PubMed ID: 18788569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
    Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenectomy for splenic metastases: a changing clinical spectrum.
    Lee SS; Morgenstern L; Phillips EH; Hiatt JR; Margulies DR
    Am Surg; 2000 Sep; 66(9):837-40. PubMed ID: 10993611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Splenectomy in cytoreductive surgery in ovarian cancer].
    Scarabelli C; Campagnutta E; Zarrelli A; De Piero G; Volpe R; Coran F
    Minerva Ginecol; 1993; 45(1-2):19-25. PubMed ID: 8469360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of splenic metastases on survival in FIGO stage IIIC epithelial ovarian cancer.
    Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
    Int J Gynecol Cancer; 2004; 14(1):51-6. PubMed ID: 14764029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solitary recurrent metastasis of epithelial ovarian cancer in the spleen.
    Farias-Eisner R; Braly P; Berek JS
    Gynecol Oncol; 1993 Mar; 48(3):338-41. PubMed ID: 8462900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic splenectomy for solitary splenic metastasis in a patient with ovarian cancer with a long disease-free interval: a case report.
    Yasuda K; Yoshimura T; Kitade H; Yanagida H; Hosaka N
    J Med Case Rep; 2018 May; 12(1):132. PubMed ID: 29759073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robotic-assisted laparoscopic splenectomy for recurrent ovarian cancer.
    Paterniti TA; Ahmad S; Holloway RW
    Int J Gynecol Cancer; 2020 Aug; 30(8):1189-1194. PubMed ID: 32624496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.